Studies to treat vision loss and Parkinson’s disease are the first to proceed under new regulations
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.